Christine Alden

The BATTLE Trial: Personalizing Therapy for Lung Cancer

Edward S. Kim, Roy S. Herbst, Ignacio I. Wistuba et al. · Cancer Discovery · 2011 · 893 citations

Medicine, Oncology, Pharmacology +17

Feasibility of Image-Guided Transthoracic Core-Needle Biopsy in the BATTLE Lung Trial

Alda L. Tam, Edward S. Kim, Marshall E. Hicks et al. · Journal of Thoracic Oncology · 2013 · 91 citations · Full text

Medicine, Oncology, Radiology +10

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

George R. Blumenschein, Pierre Saintigny, Suyu Liu et al. · Clinical Cancer Research · 2013 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and pharmacokinetics (PK) of AMG 706, panitumumab, and carboplatin/paclitaxel (CP) for the treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC)

G. R. Blumenschein, Alan Sandler, Teresa O’Rourke et al. · Journal of Clinical Oncology · 2006 · 34 citations

Medicine, Oncology, Pharmacology +17

Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.

Roy S. Herbst, George R. Blumenschein, E. S. Kim et al. · Journal of Clinical Oncology · 2010 · 29 citations

Medicine, Oncology, Pharmacology +15